&nbsp;

CapitalInvestmentStrategyExecutiveSummary.pdf

Nov 2018

Document

CapitalInvestmentStrategyTableOfContents.pdf

Nov 2018

Document

CancerFirstNationsReport.pdf

Nov 2018

Document

CancerFirstNationsReport_Accessible.pdf

Nov 2018

Regimen

CRBPIRIN

Cancer Type:

Breast,

Central Nervous System,

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Hepatobiliary / Liver / Bile Duct,

Pancreas,

Genitourinary,

Bladder / Urothelial,

Prostate,

Gynecologic,

Cervix,

Endometrial,

Ovary,

Head and Neck,

Lung,

Small Cell

, Collapse Show fewer tags

Intent: Adjuvant, Curative, Palliative

Drugs Used:

CARBOplatin,

irinotecan

... Show more tags

Quick Link(s):

Regimen Monograph

Guidelines and Advice

Cancer Care Ontario Beyond-Use Date Recommendations Report

Status: Current
ID: N/A
Version: 1

Mar 2018

Regimen

CRBPPEME(RT)

Cancer Type:

Lung,

Non-Small Cell

, Collapse Show fewer tags

Intent: Curative, Adjuvant

Drugs Used:

pemetrexed,

CARBOplatin

... Show more tags

Quick Link(s):

Regimen Monograph

Document

Clinical Trials Assessment Table

Dec 1969

Regimen

DABRTRAM

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant, Curative

Funding:

Exceptional Access Program

daBRAfenib - For the adjuvant treatment of resected Stage III cutaneous melanoma according to clinical criteria

Exceptional Access Program

trametinib - For the adjuvant treatment of resected Stage III cutaneous melanoma according to clinical criteria

, Collapse Show fewer tags

Drugs Used:

daBRAFenib,

trametinib

... Show more tags

Quick Link(s):

Regimen Monograph

Document

CCOOntarioCancerPlan4-FR.pdf

Dec 1969

Document

Defining_Advanced_Practice_in_Radiation_Therapy_A_feasibility_assessment_of_a_new_healthcare_provider_role_in_Ontario

Mar 2019

Document